Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: A population-based cohort study in Taiwan

AIDS

Volumn 28, Issue 5, 2014, Pages 709-715

  Chen, Yen Chin ^a   Li, Chung Yi ^a,b   Liu, Hsiao Ying ^a   Lee, Nan Yao ^a   Ko, Wen Chien ^a   Ko, Nai Ying ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer in situ; Cervical neoplasia; HAART; HIV; Incidence; Invasive cervical cancer

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANDIDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICATION COMPLIANCE; OPIATE ADDICTION; OPPORTUNISTIC INFECTION; PAPANICOLAOU TEST; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY ANALYSIS; SEXUALLY TRANSMITTED DISEASE; TAIWAN; THERAPY EFFECT; TREATMENT DURATION; TUBERCULOSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; COMPLICATION; HIV INFECTIONS; INCIDENCE; MIDDLE AGED; PROCEDURES; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MIDDLE AGED; RISK ASSESSMENT; TAIWAN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84897986861     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000132     Document Type: Article

References (38)

1. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997; 89: 76-80.
2. Cervical Cancer Action Webinars. Ending cervical cancer in Asia, 2012. http://www.cervicalcanceraction.org/multimedia/multimedia. [Accessed 16 February 2013]
3. Bureau of Health Promotion. Cancer registry annual report. Taipei, Taiwan: Bureau of Health Promotion; 2009, http://www.hpa.gov.tw/BHPNet/Web/Stat/ StatisticsShow.aspx?No=201304150001. [Accessed 29 July 2013].
4. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031-1037.
5. Holmes RS, Hawes SE, Touré P, Dem A, Feng Q, Weiss NS, et al. HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal. Cancer Epidemiol Biomarkers Prev 2009; 18: 2442-2446.
6. Pinto VM, Golub JE, Tancredi MV, Alencar RS, Miranda AE. Cervical cytology and histopathologic abnormalities in women living with AIDS in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 2011; 57: S212-216.
7. Chalermchockcharoenkit A, Chayachinda C, Thamkhantho M, Komoltri C. Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study. BMC Infect Dis 2011; 11: 8.
8. Adewuyi SA, Shittu SO, Rafindadi AH. Sociodemographic and clinicopathologic characterization of cervical cancers in northern Nigeria. Eur J Gynaecol Oncol 2008; 29: 61-64.
9. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-194.
10. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000; 24: 378-385.
11. Hung CC, Hsiao CF, Chen MY, Hsieh SM, Chang SY, Sheng WH, et al. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006; 59: 222-228.
12. Centers for Disease Control. Guidelines for diagnosis and treatment of HIV/AIDS. Taipei, Taiwan: Centers for Disease Control; 2008.
13. Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005. Int J Drug Policy 2008; 19: 317-323.
14. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20: 1645-1654.
15. Bratcher LF, Sahasrabuddhe VV. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer 2010; 5: 8.
16. Firnhaber C, Westreich D, Schulze D, Williams S, Siminya M, Michelow P, et al. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc 2012; 15: 17382.
17. Adler DH, Kakinami L, Modisenyane T, Tshabangu N, Mohapi L, De Bruyn G, et al. Increased regression and decreased incidence of HPV-related cervical lesions among HIV-infected women on HAART. AIDS 2012; 26: 1645-1652.
18. Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis 2010; 201: 681-690.
19. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184: 547-551.
20. Mwakigonja AR, Torres LM, Mwakyoma HA, Kaaya EE. Cervical cytological changes in HIV-infected patients attending care and treatment clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Infect Agent Cancer 2012; 7: 3.
21. Chiang TL. Taiwan's 1995 healthcare reform. Health Policy 1997; 39: 225-239.
22. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
23. Yu ST, Chang HY, Lin MC, Lin YH. Agreement between selfreported and health insurance claims on utilization of healthcare: a population study. J Clin Epidemiol 2009; 62: 1316-1322.
24. Chen MH, Su TP, Chen TJ, Cheng JY, Wei HT, Bai YM. Identification of psychiatric disorders among human immunodeficiency virus-infected individuals in Taiwan, a nine-year nationwide population-based study. AIDS Care 2012; 24: 1543-1549.
25. National Health Research Institutes. Introduction to the National Health Insurance Research Database (NHIRD). Taipei, Taiwan: National Health Research Institutes; 2012, http://nhird.nhri.org.tw. [Accessed 8 August 2012].
26. Centers for Disease Control. Statistics of HIV/AIDS. Taipei, Taiwan: Centers for Disease Control; 2012, http://www.cdc.gov.tw/english/submenu.aspx? treeid=00ed75d6c887bb27&no wtreeid=f6f562fd95fd8df9. [Accessed 5 August 2012].
27. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 2006; 4: e22.
28. Gay CL, Mayo AJ, Mfalila CK, Chu H, Barry AC, Kuruc JD, et al. Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection. AIDS 2011; 25: 941-949.
29. Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother 2011; 45: 372-379.
30. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-tomoderate adherence levels. PLoS One 2008; 3: e2783.
31. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-432.
32. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-1510.
33. Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001; 94: 753-757.
34. Kadhel P, Multigner L, Bardinet F, Goerger-Sow M, Janky E. Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies. HIV Med 2012; 13: 79-82.
35. Chen YC, Liu HY, Li CY, Lee NY, Ko WC, Chou CY, et al. Low papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010. J Womens Health (Larchmt) 2013; 22: 1016-1022.
36. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009; 100: 840-847.
37. Sekirime WK, Gray R. HIV infection among Uganda women with cervical cancer: a retrospective study. Gynecol Obstet Invest 2007; 63: 222-228.
38. van Bogaert LJ. Age at diagnosis of preinvasive and invasive cervical neoplasia in South Africa: HIV-positive versus HIVnegative women. Int J Gynecol Cancer 2011; 21: 363-366.